Status:
COMPLETED
Transarterial Chemoembolization Plus Hypofractionnated Radiotherapy vs. Surgery in Locally Advanced Hepatocellular Carcinoma: an IPTW Comparison
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Non-metastatic Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Patients with non-metastatic unresectable hepatocellular carcinoma
Eligibility Criteria
Inclusion
- Age ≥18 years of age
- ECOG 0-2
- Histologically proven hepatocellular carcinoma or proven according to radiological and biochemical criteria (EASL-AASLD) in cirrhotic patients
- Child-Pugh class A
- Absence of truncular or lobar portal vein invasion, or suprahepatic vein invasion
Exclusion
- Uncontrolled replication of hepatitis B virus
- Transplanted liver
- Previous abdominal irradiation
- Previous treatment of HCC with systemic therapy, or with surgical resection in the 2 previous years
- Metastatic illness
Key Trial Info
Start Date :
October 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 15 2021
Estimated Enrollment :
163 Patients enrolled
Trial Details
Trial ID
NCT04823715
Start Date
October 15 2020
End Date
January 15 2021
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Croix-Rousse Hospital, Hospices Civils de Lyon
Lyon, France, 69004